Acupuncture Versus Sham Acupuncture for Tinnitus

ConditionTinnitus
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorShanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University

About this trial

This multicenter, randomized, sham-controlled clinical trial will evaluate the efficacy and safety of acupuncture for patients with subjective idiopathic tinnitus. A total of 226 eligible participants will be randomly assigned to receive either acupuncture or sham acupuncture. Both groups will receive treatment for 5 weeks. The primary outcome is the change in Tinnitus Handicap Inventory score from baseline to Week 5. Secondary outcomes include tinnitus loudness, tinnitus severity, sleep quality, anxiety, depression, audiological assessments, and adverse events. Exploratory neuroimaging outcomes include functional magnetic resonance imaging and magnetoencephalography measures.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Tinnitus as the primary complaint, meeting the diagnostic criteria for subjective idiopathic tinnitus.

Tinnitus duration of at least 6 months.

Patent external auditory canal and intact tympanic membrane.

Bilateral pure tone average no greater than 80 decibels hearing level (dB HL).

Disqualifiers

Inner ear or auditory nerve disorders, including sudden sensorineural hearing loss, Meniere disease, otosclerosis, or acoustic neuroma.

External or middle ear diseases, including otitis externa, foreign body in the external auditory canal, eczema of the external auditory canal, cerumen impaction, acute or chronic otitis media with effusion, or acute or chronic suppurative otitis media.

Non-otogenic tinnitus caused by acute or chronic systemic diseases involving hematologic, endocrine, renal, or other major organ systems.

Objective tinnitus, including myogenic, vascular, or patulous eustachian tube-related tinnitus.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Acupuncture

    Procedure/Surgery

    Standardized acupuncture treatment will be administered twice weekly for 5 consecutive weeks, with 10 sessions in total. Acupuncture will be performed at Tinghui (GB2), Shuaigu (GB8), Taixi (KI3), Taibai (SP3), Yifeng (TE17), and Zhigou (TE6). Needles will be inserted according to standardized acupoint locations and retained for 20 minutes. Participants will also receive tinnitus-related health education.

  • Sham Acupuncture

    Procedure/Surgery

    Non-penetrating sham acupuncture will be administered twice weekly for 5 consecutive weeks, with 10 sessions in total. The same acupoints as the acupuncture group will be used. Blunt-tip needles will contact the skin surface without skin penetration or manual needle manipulation. Needles will be retained for 20 minutes. Participants will also receive tinnitus-related health education.

Treatment groups

226 Participants
are divided into 2 treatment groups
Group A: AcupunctureExperimental treatment 1 intervention
Group B: Sham AcupunctureSham comparator 1 intervention

Trial outcomes

Primary outcomes

1

Change in Tinnitus Handicap Inventory Score From Baseline to Week 5

The Tinnitus Handicap Inventory is a 25-item questionnaire used to assess tinnitus-related handicap. The total score ranges from 0 to 100, with higher scores indicating more severe tinnitus-related handicap. The primary outcome is the change in Tinnitus Handicap Inventory score from baseline to Week 5.

Time frame
Baseline and Week 5

Secondary outcomes

1

Change in Pittsburgh Sleep Quality Index Score

The Pittsburgh Sleep Quality Index is used to assess sleep quality. Higher scores indicate poorer sleep quality. The change from baseline will be compared between the acupuncture and sham acupuncture groups.

Time frame
Baseline, Week 1, Week 3, Week 5, Week 9, and Week 17
2

Change in Tinnitus Loudness Visual Analog Scale Score

The tinnitus loudness visual analog scale is used to assess perceived tinnitus loudness. Higher scores indicate greater tinnitus loudness. The change from baseline will be compared between groups.

Time frame
Baseline, immediately after the first treatment session, Week 1, Week 3, Week 5, Week 9, and Week 17
3

Change in Tinnitus Severity Visual Analog Scale Score

The tinnitus severity visual analog scale is used to assess the subjective severity or impact of tinnitus. Higher scores indicate greater tinnitus-related severity or impact. The change from baseline will be compared between groups.

Time frame
Baseline, Week 1, Week 3, Week 5, Week 9, and Week 17
4

Change in Self-Rating Anxiety Scale Score

The Self-Rating Anxiety Scale is used to assess anxiety symptoms. Higher scores indicate more severe anxiety symptoms. The change from baseline will be compared between groups.

Time frame
Baseline, Week 1, Week 3, Week 5, Week 9, and Week 17

Other outcomes

1

Change in Magnetoencephalography (MEG) Power Spectral Density

Magnetoencephalography will be used as an exploratory neuroimaging outcome to assess changes in brain power spectral density from baseline.

Time frame
Baseline, after the first treatment session, and Week 5
2

Change in Functional Magnetic Resonance Imaging (fMRI) Functional Connectivity

Functional magnetic resonance imaging will be used as an exploratory neuroimaging outcome to assess changes in brain functional connectivity from baseline.

Time frame
Baseline and Week 5

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University

Lead sponsor

Shanghai University of Traditional Chinese Medicine

Collaborator

This trial is not recruiting at the moment. You can still explore other options: